Simplex Trading’s Adicet Bio ACET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.3K Buy
1,800
+100
+6% +$749 ﹤0.01% 7165
2025
Q4
$14.3K Buy
+1,700
New +$18.8K ﹤0.01% 6752
2025
Q2
Sell
-475
Closed -$5K 8485
2025
Q1
$5K Buy
+475
New +$6.79K ﹤0.01% 7509
2024
Q3
Sell
-100
Closed -$1K 8340
2024
Q2
$1K Sell
100
-500
-83% -$13.4K ﹤0.01% 8402
2024
Q1
$22K Buy
600
+550
+1,100% +$22.8K ﹤0.01% 7004
2023
Q4
$1K Hold
50
﹤0.01% 8415
2023
Q3
$1K Buy
50
+19
+61% +$671 ﹤0.01% 8229
2023
Q2
$1K Sell
31
-200
-87% -$17.7K ﹤0.01% 8549
2023
Q1
$21K Buy
231
+218
+1,677% +$27.4K ﹤0.01% 6845
2022
Q4
$1K Sell
13
-531
-98% -$133K ﹤0.01% 8737
2022
Q3
$123K Buy
544
+169
+45% +$42.9K ﹤0.01% 5236
2022
Q2
$87K Buy
375
+350
+1,400% +$76.9K ﹤0.01% 5747
2022
Q1
$7K Sell
25
-38
-60% -$8.74K ﹤0.01% 9135
2021
Q4
$17K Buy
+63
New +$10.8K ﹤0.01% 8526
2020
Q4
Sell
-3
Closed -$47K 8235
2020
Q3
$47K Buy
+3
New +$759 ﹤0.01% 5647
2020
Q2
Hold
0
7323
2020
Q1
Hold
0
-$5K 7496
2019
Q4
Hold
0
6671

Other funds holding ACET

Simplex Trading's ACET Position: Q1 2026 in Review

Simplex Trading increased its Adicet Bio (ACET) stake by 1,501% in Q1 2026, buying an estimated $9.78K and bringing the position to 1,393 shares worth $9.49K. The position accounts for ﹤0.01% of the portfolio, ranked #7408.

Simplex Trading first reported a position in ACET in Q4 2019 and has held it in 17 quarters since. The position peaked at $295K in Q4 2021. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Simplex Trading held 1,393 shares of Adicet Bio worth $9.49K as of Q1 2026.
  • Simplex Trading bought 1,306 Adicet Bio shares in Q1 2026, an estimated $9.78K.
  • Adicet Bio made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7408 holding.
  • Simplex Trading first reported a position in Adicet Bio in Q4 2019 and has held it in 17 quarters since.
  • Simplex Trading's Adicet Bio position peaked at $295K in Q4 2021.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.